T he replacement of pancreatic endocrine tissue through islet transplantation offers a physiological approach for precise restoration of euglycemia in individuals with type I diabetes. Unfortunately, islet allograft rejection is a significant obstacle in the application of such a therapy. It has been known for some time that a variety of allogeneic tissues, including pancreatic islets, survive transplantation without any requirement for systemic immunosuppression, provided they are grafted into abdominal testis (1-3). Sertoli cells are thought to confer immune privilege to the testis, probably by producing factors that act locally to inhibit immune responses. More recently, it has been shown that allografts consisting of purified Sertoli cells Address correspondence and reprint requests to Dr. Ray V. Rajotte, Director, Surgical-Medical Research Institute, 1074 Dentistry/Pharmacy Building, University of Alberta, Edmonton, Alberta, Canada T6G 2N8. Email: rrajotte@gpu.srv.ualberta.ca.
alone can survive long term in immunocompetent mice (4) . Since implantation into the testis has several practical disadvantages, Selawry and Cameron (5) have pursued the idea that allogeneic islets might be protected from rejection if they were transplanted together with purified Sertoli cells (i.e., dominant bystander immunoprivilege conferred on the islets by the Sertoli cells). The long-term reversal of diabetes in their rat model, however, was only seen in those animals also receiving a course of cyclosporine A (CsA) in the immediate posttransplant period. We hypothesized that this transient requirement for CsA might be due to the failure of the purified Sertoli cells to be fully functional immediately posttransplantation. We therefore altered the procedure for the preparation and transplantation of the testicular cells. Rather than a complex series of digestions and washes, utilizing sequentially high concentrations of trypsin, collagenase, and finally hyaluronidase (5), we adopted a simpler and more gentle approach that isolated a less highly purified population of Sertoli cells. And, instead of transplanting the tissue immediately after isolation, we first cultured the testicular cells in vitro for 48 h in media containing 5% autologous rat serum. This incubation was carried out in petri dishes that had not been precoated for tissue-culture so that the original single cell suspension did not form a monolayer on the bottom of the plate but rather formed cellular aggregates. Transplants were then performed to determine if islet grafts placed under the renal subcapsular space could be protected from allorejection when cotransplanted with reaggregated testicular cells.
RESEARCH DESIGN AND METHODS

Animals. Male Lewis rats (RT1
171
; Charles River Canada, St. Constant, Quebec, Canada) were used as islet (aged 8-10 weeks) and testicular (aged 2-3 weeks) cell donors. Male Wistar-Furth rats (RTl llAl ; Harlan-Sprague Dawley, Indianapolis, IN), aged 6-8 weeks, were used as recipients. Rats were rendered diabetic with streptozotocin (65 mg/kg body wt, intravenously; Upjohn, Kalamazoo, MI) 14-21 days before transplantation. Only those animals exhibiting nonfasting blood glucose values >20 mmol/1 were used as recipients. Blood samples were obtained from the tail vein of nonfasted animals for glucose assay (Medisense glucose meter, Medisense Canada, Mississauga, Ontario, Canada) three times per week, and the return to the diabetic state was defined as occurring when blood glucose concentrations exceeded 11.4 mmol/1 on two consecutive readings. Care and maintenance of all animals was in accordance with the guidelines of the University of Alberta animal care committee.
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FIG. 1. Electron micrographs of Sertoli cells within testicular cell aggregates (A) and within a functioning composite islet allograft (B~)
.Ai electron micrograph of a testicular cell aggregate after 48 h of in vitro culture, immediately before transplantation (4,600 X ). The field shows several Sertoli cells, characterized by one or more indentations along the course of the nuclear membrane, and a filamentous zone just inside the nuclear membrane. Two prominent germ cells, characterized by circular and more darkly stained nuclei, are also seen. At higher magnification (inset, 19,000x), the filamentous zone associated with the inner surface of the nuclear membrane is more clearly seen, as are multiple tight junctions between two adjacent Sertoli cells (arrowheads). B: electron micrograph of a fully functioning composite islet-testicular cell allograft, harvested from a normoglycemic animal 105 days posttransplantation (6,600x). Engrafted P-cells appear well granulated and are in direct contact with a Sertoli cell (inset, 18,000 X). Scale bar, 1 um.
Graft preparation and transplantation. Pancreatic islets were prepared by collagenase digestion, Ficoll density gradient purification, and culture for 2 days at 22°C in CMRL1066 (Gibco, Burlington, Ontario, Canada) containing 5.6 mmol/1 D-glucose, 2 mmol/1 L-glutamine, 10 mmol/1 HEPES, 2% heatinactivated fetal calf serum (Gibco), 100 U/ml penicillin, and 100 jig/ml streptomycin.
Testicles from 15-to 21-day-old Lewis rats were collected in Hanks' balanced salt solution (HBSS), chopped into 1-mm pieces with scissors, and digested for 10 min at 37°C with collagenase (2.5 mg/ml; Sigma Type V, St. Louis, MO) in HBSS. The digest was washed three times with calcium-and magnesium-free HBSS containing 1 mmol/1 EDTA and 0.5% bovine serum albumin (Sigma) (HBSS/EDTA), digested for 10 min at 37°C with trypsin (25 ug/ml; Boehringer Mannheim, Laval, Canada) and DNase (4 ug/ml, Boehringer) in HBSS/EDTA, and washed four times in HBSS; the final cell pellet was resuspended in HAM's F10 media supplemented with 10 mmol/1 D-glucose, 2 mmol/1 L-glutamine, 50 umol/1 isobutylmethylxanthine, 0.5% bovine serum albumin, 10 mmol/1 nicotinamide, 100 U/ml penicillin, 100 ug/ml streptomycin, and 5% Lewis rat serum (not heat inactivated). The tissue was passed through a 500-um mesh, placed in nontissue culture-coated Petri dishes, and incubated for 48 h at 37°C (5% CO 2 ) before transplantation.
After the 2-day culture period, samples were taken from both islet and reaggregated testicular cell preparations for the determination of their cellular composition by electron microscopy (6). Briefly, tissues were fixed in 2.5% (vol/vol) glutaraldehyde (Millonig's buffer, pH 7.2), postfixed in 1.5% (wt/vol) OsO 4 , washed in distilled water, and then dehydrated successively in 50,70,80,90, and 100% ethanol, before embedding in araldite. Ultrathin (1-um) sections were stained with lead citrate and uranyl acetate and then subsequently examined using a Hitachi H 7000 transmission electron microscope.
Each diabetic recipient received 2,000 hand-picked Lewis islets (>100 um diameter) alone or in combination with two different doses of Lewis testicular cell aggregates. Composite grafts were prepared by mixing islets and testicular cell aggregates in polypropylene microcentrifuge tubes. Grafts were aspirated into polyethylene tubing (PE-50), pelleted by centrifugation, and gently placed under the left renal subcapsular space of Halothane-anesthetized animals. The number of testicular cells grafted in each experiment was assessed by measuring the DNA content of triplicate representative aliquots of each reaggregated cell preparation before transplantation, and calculations were based on our observation that the freshly isolated testicular cells contained -20 pg DNA/cell (i.e., the total DNA content transplanted per 20 pg DNA per testicular cell equals the testicular cell number). Characterization of the harvested grafts. Grafts were examined from recipients at the time of return to a hyperglycemic state and at various times from euglycemic recipients. The graft-bearing kidneys were immersed in Bouin's solution overnight, embedded in paraffin, and sections 5-um thick were stained with hematoxylin-eosin. For immunohistochemistry, sections were counterstained with Harris's hematoxylin, then we used the streptavidin-biotin complex (ABC)-method with alkaline-phosphatase and Vector red as chromagen and, for double staining, with ABC-peroxidase and diaminobenzadine as the chromagen. Primary antibodies included guinea pig anti-porcine insulin (1:1,000; Dako, Carpinteria, CA), mouse monoclonal anti-vimentin (1:25; Dako), and rabbit anti-human FasL (1:25; Santa Cruz Biotech, Santa Cruz, CA). Biotinylated secondary antibodies and the ABC-enzyme complexes were purchased from Vector Laboratories (Burlingame, CA). Primary antibodies were incubated for 30 min (room temperature), while secondary antibodies were applied for 20 min. In one recipient, a section of the graft was fixed in glutaraldehyde and then processed for electron microscopy.
RESULTS
At the time of transplantation, the 2-day cultured islet grafts consisted predominately of structurally intact cells (>90%), identified as endocrine (80-90%), nongranulated (5-15%), or exocrine (<5%). Tissue culture of freshly isolated testicular single cell suspensions resulted in the formation of cellular aggregates ranging in diameter from 50 to 150 um. Electron micrographs of reaggregated testicular cell preparations, examined immediately before transplantation, indicated that they consisted of >75% Sertoli cells, with the remainder of cells being almost exclusively germ cells (Fig. L4) . One particular observation was the fact that tight junctions had formed between the Sertoli cells within the aggregates (Fig.  L4, insert) .
All animals receiving islet allografts alone achieved euglycemia within 2 days, but returned to a diabetic state by 5-14 days posttransplantation (mean survival time, 10 ± 2 days; Table 1 ). When islets were cotransplanted with testicular cell aggregates consisting of 5.5 X 10 6 cells, all animals again normalized within 2 days, but returned to a diabetic state by 9-13 days posttransplantation (mean survival time, 11 ± 1 days). However, when we doubled the quantity of testicular cell aggregates placed in the composite grafts (i.e., up to 11.0 X 10 6 cells), all of the animals remained normoglycemic throughout the follow-up period and returned to the diabetic state only when the kidneys bearing the composite islet-testicular cell allografts were removed (Table 1; Fig. 2 ). To ascertain whether the previously engrafted Lewis islets plus testicular cells had induced a state of donor-specific tolerance, we retransplanted these nephrectomized animals (n = 5) with Lewis islets alone under the remaining kidney capsule. The rejection of islet allografts was considered to have occurred when the nonfasting blood glucose concentrations exceeded 11.4 mmol/1 on two consecutive readings. *Ongoing; tgraft-bearing kidneys were removed for morphological assessment from normoglycemic recipients at the times indicated, and all animals were subsequently monitored for blood glucose levels to confirm a return to hyperglycemia. 
FIG. 2. Function of composite
Lewis islet-testicular cell allografts (2,000 islets plus 11 X 10 6 testicular cells) transplanted into diabetic Wistar-Furth animals. Fasting blood glucose concentrations (monitored three times per week) are shown from the time of transplantation (day 0) to the time when the graft-bearing kidneys were removed (*), either 98 days 04; n = 2) or 105 days (B; n = 3) posttransplantation. All animals returned to the diabetic state following the removal of the graft, and all were subsequently retransplanted under the right kidney capsule 2 days later with 2,000 allogeneic Lewis islets alone (arrows).
All animals rapidly rejected the second islet allograft in a normal manner, with a mean survival time of 10.3 ± 1.2 days ( Figs. 2A and B) .
Histological analysis of graft-bearing kidneys was performed by hematoxylin-eosin and immunohistochemical staining to detect the presence of pancreatic (3-cells (insulin) and cotransplanted Sertoli cells (vimentin and FasL) (Fig. 3) . Graft tissue from the control animals, harvested at the time of return to the diabetic state, revealed an extensive lymphocytic infiltrate (Fig. 3A) and the complete absence of insulin-positive cells (insulin staining not shown). Compared with the control grafts, the composite allografts from animals receiving 5.5 X 10 6 testicular cells, again harvested at the time of diabetes, demonstrated considerably fewer lymphocytes that were more diffusely distributed (Fig. 3B) . Immunohistochemical staining revealed the presence of a few islands of insulin-positive cells (Fig. 3(7) , but these same sections showed no staining for Sertoli cells (i.e., they were negative for both vimentin and Fas ligand; data not shown). In contrast, functioning composite allografts from rats receiving 11.0 X 10 6 testicular cells, harvested from normoglycemic animals at -100 days posttransplantation, showed negligible lymphocytic infiltration and numerous intact islets (Fig. 3D) . In all recipients, double immunohistochemical staining revealed the presence of well-granulated insulin-positive cells in close proximity to vimentin-positive (Fig. 3E) and FasL-expressing (Figs. 3F and G) Sertoli cells. When examined by electron microscopy, these composite grafts were seen to consist of ultrastructurally intact endocrine cells in close association with Sertoli cells (Fig. IB) .
DISCUSSION
There are likely several reasons why our composite rat islet plus Sertoli cell allografts were able to survive long-term without requiring CsA, whereas those of Selawry and Cameron (5) were not. As described above, we modified the method for isolating the testicular cells and added a period of in vitro culture, which potentially allows the isolated cells to recover before transplantation. It is also possible that the aggregated state of the Sertoli cells, which allows the formation of intercellular tight junctions (Fig. LA) , also promotes intercellular cooperation and creates a more functional effector unit, more closely resembling the organization of Sertoli cells within the seminiferous tubule. The process of aggregation and the function of the resulting testicular cell aggregates may also have been promoted initially because cellular elements in addition to Sertoli cells (i.e., germ cells; Fig. LA ) were also present in our cell preparation, although these would not be expected to survive long-term at the higher body temperature. Our grafts may have also contained more Sertoli cells than those of Selawry and Cameron (5); and, on a purely technical level, since we transplanted cell aggregates rather than a single cell suspension, it was easier to ensure that the desired number of Sertoli cells were placed with, and remained juxtapostioned to, the islet allografts. It is also possible that some of the proteins secreted by Sertoli cells (e.g., insulin-growth factor I, transforming-growth factor (B, laminin, etc. [7] ) may directly promote the survival of islet cells. In addition, further studies will be required to determine the best methods for isolating and culturing testicular cells so that they achieve the optimal physical state and are maximally effective when cotransplanted with islet allografts. Clearly, by using our current method, the minimum number of testicular cells required is relatively large, and it is possible that by using other methods this number could be reduced. The precise mechanism whereby our pancreatic islet allografts are protected from immune rejection by the cotransplantation of allogeneic testicular cell aggregates (largely Sertoli cells) remains to be elucidated, although the immune regulatory protein Fas ligand (FasL) likely plays a key role. Clearly, the composite grafts that survived long-term continued to express FasL (Figs. 3Fand G) . The expression of FasL (and soluble FasL) in the anterior chamber of the eye has been shown to be necessary, although perhaps not sufficient, for the maintenance of the immunoprivileged status of this site (8, 9) , and the expression of FasL by testicular Sertoli cells has been shown to be a prerequisite for these cells to survive transplantation across allogeneic barriers (4). Since Sertoli cells are known to express (and to secrete) a very large number of different proteins (7), it is unclear if FasL alone is sufficient to confer immunoprivilege to an immediately actfacent allograft. and cotransplanting the engineered myoblasts together with purified C3H (H-2 k ) islets into chemically diabetic C57BL/6 mice. In these experiments, two of eight animals receiving the composite grafts with 1 X 10 6 FasL myoblasts and three of eight animals receiving the composite grafts with 2 X 10 6 FasL myoblasts remained diabetes free for >100 days. All animals that received >0.5 x 10 6 FasL myoblasts showed at least some delay in diabetes recurrence, and graft failure was attributed to the loss of FasL transgene expression by the myoblasts. The tentative theoretical conclusion of Lau's experiments is that FasL may be necessary and sufficient to confer immune privilege to adjacent allogeneic islets. However, the more certain practical conclusion of this work is that the problem of maintaining long-term expression of transgenes in transfected (or transduced) primary cells will be a major barrier to the clinical application of this approach, as it is for many other gene therapy applications in humans. There are also additional practical issues of safety and regulatory approval associated with any new gene therapy protocol. In contrast, the approach we have described above using allogeneic testicular cell aggregates to prevent islet allograft rejection should be immediately applicable to human islet transplantation, provided that it can first be proven in a large animal model. Because we are using allogeneic testicular cells, the tissue should be readily available from the majority of male organ donors, and because we are using Sertoli cells themselves, the issue of whether or not FasL alone is sufficient to confer immune privilege does not arise.
